It's time for the world to realize that attacking the Amyloid is not the answer to ALZ. Preventing it upstream vis sigma receptor and Blarcamasine will be the answer. The EMA knows that. The FDA will eventually come to that realization. Better late than never.
HHS Secretary Robert F. Kennedy Jr. said during a January confirmation hearing that stymied Alzheimer’s research epitomizes wider problems at NIH, where hierarchies can perpetuate irreproducible research and box out novel ideas.
“We’ve lost 20 years in figuring out a cure for Alzheimer’s,” Kennedy said.
This is why imo Dr. Missling is taking this all the way across the goal line to market. Alzheimers runs in his family with his Grampa having it, ie, no partnership until after approval.
HHS Secretary Robert F. Kennedy Jr. said during a January confirmation hearing that stymied Alzheimer’s research epitomizes wider problems at NIH, where hierarchies can perpetuate irreproducible research and box out novel ideas.“We’ve lost 20 years in figuring out a cure for Alzheimer’s,” Kennedy said.
By contrast, Hardy argued in the email to Perry that clinical trials of drugs targeting amyloid provide strong evidence that the amyloid cascade hypothesis remains solid. “Amyloid therapies are working and real-world data from Wash U and Mayo and possibly elsewhere looks better than the trials (admittedly with very careful patient selection),” he wrote. “It looks like the next round of drugs … will be both better and safer.”
So RFK Jr. is open to AVXL's novel therapy, and the bureaucracy is in cahoots with the Amyloid mafia. Sound as if research funding pre-Trump was as corrupt as global warming research funding.